Heparin Pharmacokinetics During Hemodialysis
- 1 November 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 11 (6) , 674-679
- https://doi.org/10.1097/00007691-198911000-00011
Abstract
The disposition of heparin was studied in 21 chronic hemodialysis patients. Heparin was administered as a bolus injection in doses of 3,000-12,000 U. Combined zero and first-order elimination was demonstrated, with heparin half-life declining by 74% over 3.5 h during dialysis. Assumption of a first-order pharmacokinetic model of elimination resulted in a mean difference of 0.001 U/ml between actual and predicted heparin concentrations. Mean first-order pharmacokinetic parameters were: half-life, 117 min; heparin volume of distribution (V), 68 ml/kg; clearance, 28 ml/min. A high degree of interpatient variability was also observed. A comparison of V and plasma volume (PV) revealed V to be significantly greater than PV (p < 0.001), indicating distribution outside the plasma compartment. When compared to blood volume, there was no significant difference (p > 0.1), indicating that blood volume may be used to approximate V. The nonlinear component of the elimination process is not clinically significant within the range of therapeutic plasma concentrations used during hemodialysis, but the high degree of interpatient variability indicates that dosage individualization may be useful.This publication has 9 references indexed in Scilit:
- Heparin kinetics: Variables related to disposition and dosageClinical Pharmacology & Therapeutics, 1981
- Preventing hemorrhage in high-risk hemodialysis: Regional versus low-dose heparinKidney International, 1979
- PHARMACOKINETICS OF HEPARIN .1. STUDIES OF DOSE DEPENDENCE IN RATS1979
- PHARMACOKINETICS OF HEPARIN .2. STUDIES OF TIME-DEPENDENCE IN RATS1979
- Heparin Pharmacokinetics: Increased Requirements in Pulmonary EmbolismBritish Journal of Haematology, 1978
- Heparin kinetics in venous thrombosis and pulmonary embolism.Circulation, 1976
- HEPARIN ELIMINATION IN UREMIC PATIENTS ON HEMODIALYSIS1976
- LABORATORY OBSERVATIONS AND CLINICAL IMPLICATIONS OF MONITORING EFFECT OF HEPARIN BY BIOASSAY1976
- PREDICTION OF BLOOD VOLUME AND ADIPOSITY IN MAN FROM BODY WEIGHT AND CUBE OF HEIGHT1956